Scaffold, endovascular non-coronary, resorbable drug eluting, with delivery system (implantable)
Code effective Apr 01, 2026
HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System
C1743 is a valid 2026 HCPCS code meaning Scaffold, endovascular non-coronary, resorbable drug eluting, with delivery system (implantable) or (Scafld endovas resrb drg elu) for short. HCPCS C1743 has been effective since 04/01/2026 and applies to Surgery.
|
HCPCS Level II Code Section C - Temporary Codes for Use with Outpatient Prospective Payment System |
|
| HCPCS Code | C1743 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
53 - Statute
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Statute number | 1833(t) |
| Coverage code | D - Special coverage instructions apply |
| ASC payment group code | Effective Apr 01, 2026 - This procedure is approved to be performed in an ambulatory surgical center. |
| BETOS2 code | P1G - Major procedure - Other |
| HCPCS Action code | A - Add procedure or modifier code |
| Type of service | 2 - Surgery |
| Effective date | Effective Apr 01, 2026 |
| Date added | Added Apr 01, 2026 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.